LIS Technologies Inc., a NYC-based proprietary developer of advanced laser technology and the only USA-origin patented laser uranium enrichment company, closed a $1.3m seed funding round.
Led by Christo Liebenberg, Chief Executive Officer, and Jeff Eerkens, Ph.D., Chief Technical Officer, LIS Technologies is a proprietary developer of a patented advanced laser technology, making use of infrared wavelengths to selectively excite the molecules of desired isotopes to separate them from other isotopes. The Laser Isotope Separation Technology (L.I.S.T) has a huge range of applications, including being the only USA-origin and patented laser uranium enrichment company, and several major advantages over traditional methods such as gas diffusion, centrifuges, and prior art laser enrichment. The LIST proprietary laser-based process is more energy-efficient and has the potential to be deployed with highly competitive capital and operational costs. L.I.S.T is optimized for LEU (Low Enriched Uranium) for existing civilian nuclear power plants, High-Assay LEU (HALEU) for the next generation of Small Modular Reactors (SMR) and Microreactors, the production of stable isotopes for medical and scientific research, and applications in quantum computing manufacturing for semiconductor technologies.
This investment will partially fund Phase 0 of the company’s 4-step phased approach and mission to rejuvenate laser enrichment capabilities in the U.S. and breathe new life into the CRISLA technology, optimized for LEU and HALEU nuclear fuel.
The company’s proprietary CRISLA technology has potential applications spanning uranium enrichment for nuclear fuel, the synthesis of stable isotopes critical for medical and other scientific research, and in the growing field of quantum computing, particularly in the manufacturing of semiconductor technologies.
FinSMEs
25/03/2024